Viking Therapeutics VKTX
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$187.11M-89.8% YoY
Net profit-$183.19M-101.8% YoY
Diluted EPS-$1.55-91.4% YoY
Free cash flow-$138.19M-47.0% YoY
Operating cash flow-$138.19M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-96.4%
Return on assets-73.1%
Return on invested capital-83.3%
Current ratio7.27
Liabilities / assets39.8%
Cash & investments$959.81M
Total debt$254.67M
Net cash (debt)$705.14M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $187.11M | $132.60M | $164.13M | $393.34M | $164.74M |
| Selling and Admin Expenses | $20.31M | $16.84M | $13.98M | $48.39M | $11.28M |
| -General & Admin Expense | $20.31M | $16.84M | $13.98M | $48.39M | $11.28M |
| Research & Development | $166.80M | $115.75M | $150.15M | $344.96M | $153.46M |
| Operating Profit | -$187.11M | -$132.60M | -$164.13M | -$393.34M | -$164.74M |
| Net Non-Operating Interest Income (Expense) | $3.93M | $4.55M | $5.80M | $33.65M | $7.04M |
| Non-Operating Interest Income | $4.01M | $4.55M | $5.80M | $33.70M | $7.04M |
| Non-Operating Interest Expense | $88,000.00 | – | – | – | – |
| Pretax Profit | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Net Profit | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Profit from Continuing Operations | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Net Income to Parent Company | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Net Income to Common Stockholders | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Basic EPS | -$1.55 | -$1.10 | -$1.37 | -$3.19 | -$1.38 |
| Diluted EPS | -$1.55 | -$1.10 | -$1.37 | -$3.19 | -$1.38 |
| Other Income (Expense) | – | $30,000.00 | – | $55,000.00 | $41,000.00 |
| Gain on Sale of Security | – | $30,000.00 | – | $55,000.00 | $41,000.00 |
| Total Other Finance Costs | – | – | – | $56,000.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $977.17M | $521.90M | $608.24M | $715.73M | $715.73M |
| Total Current Assets | $973.00M | $517.56M | $608.21M | $715.60M | $715.60M |
| Cash and Cash Equivalents & Short-Term Investments | $959.81M | $501.66M | $602.96M | $705.74M | $705.74M |
| -Cash and Cash Equivalents | $677.61M | $125.75M | $118.12M | $165.81M | $165.81M |
| -Short Term Investments | $282.20M | $375.91M | $484.85M | $539.93M | $539.93M |
| Prepaid Assets | $10.01M | $14.96M | $4.02M | $8.05M | $8.05M |
| Other Current Assets | $3.18M | $941,000.00 | $1.22M | $1.81M | $1.81M |
| Total Non-Current Assets | $4.17M | $4.33M | $33,000.00 | $131,000.00 | $131,000.00 |
| Net PPE | $3.85M | $4.01M | $0.00 | $85,000.00 | $85,000.00 |
| -Gross PPE | $3.85M | $4.01M | $0.00 | $85,000.00 | $85,000.00 |
| Non-Current Prepaid Assets | $113,000.00 | $113,000.00 | $33,000.00 | $46,000.00 | $46,000.00 |
| Other Non-Current Assets | $202,000.00 | $211,000.00 | – | – | – |
| Total Liabilities | $388.57M | $113.58M | $106.33M | $76.67M | $76.67M |
| Total Current Liabilities | $133.90M | $109.66M | $106.33M | $76.67M | $76.67M |
| Payables | $82.13M | $69.01M | $67.18M | $53.25M | $53.25M |
| -Accounts Payable | $82.13M | $69.01M | $67.18M | $53.25M | $53.25M |
| Current Accrued Expenses | $51.74M | $40.48M | $39.14M | $23.28M | $23.28M |
| Short-Term Debt and Capital Lease Obligation | $24,000.00 | $161,000.00 | – | $137,000.00 | $137,000.00 |
| -Current Capital Lease Obligation | $24,000.00 | $161,000.00 | $0.00 | $137,000.00 | $137,000.00 |
| Total Non-Current Liabilities | $254.67M | $3.93M | $0.00 | $0.00 | $0.00 |
| Long Term Debt and Capital Lease Obligation | $254.67M | $3.93M | – | $0.00 | $0.00 |
| -Long Term Debt | $250.66M | – | – | – | – |
| -Long Term Capital Lease Obligation | $4.01M | $3.93M | – | $0.00 | $0.00 |
| Total Equity | $588.60M | $408.32M | $501.92M | $639.06M | $639.06M |
| Stockholders' Equity | $588.60M | $408.32M | $501.92M | $639.06M | $639.06M |
| Capital Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Common Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.91B | $1.54B | $1.51B | $1.49B | $1.49B |
| Retained Earnings | -$1.32B | -$1.13B | -$1.01B | -$847.55M | -$847.55M |
| Gains/Losses Not Affecting Retained Earnings | -$1.70M | -$1.15M | -$856,000.00 | $378,000.00 | $378,000.00 |
| Less: Treasury Stock | – | – | $0.00 | $0.00 | $0.00 |
| Non-Current Deferred Assets | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| Net cash flow from continuing operations | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| Net Income from Continuing Operations | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| Gain/Loss from Continuing Operations | $0.00 | – | – | -$55,000.00 | -$41,000.00 |
| Depreciation & Depletion & Amortization | $158,000.00 | $157,000.00 | $85,000.00 | $431,000.00 | $94,000.00 |
| Other Non-Cash Items | $91,000.00 | $111,000.00 | $1,000.00 | $66,000.00 | -$16,000.00 |
| Change in Working Capital | $27.65M | -$7.64M | $35.22M | $48.98M | $65.48M |
| -Change in Receivables | $1.47M | $120,000.00 | $936,000.00 | $5.08M | $413,000.00 |
| -Change in Prepaid Assets | $2.71M | -$10.74M | $4.63M | -$5.20M | $14.28M |
| -Change in Payables and Accrued Expense | $23.61M | $3.17M | $29.79M | $49.61M | $50.90M |
| -Change in Other Current Liabilities | -$139,000.00 | -$191,000.00 | -$139,000.00 | -$505,000.00 | -$116,000.00 |
| Net cash flow from investing | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| Net Cash Flow from Continuing Investing Activities | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| Net Investment Purchase and Sale | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| Financing Cash Flow | $597.55M | $23.59M | $12.08M | $76.44M | $75.10M |
| Net Cash Flow from Continuing Financing Activities | $597.55M | $23.59M | $12.08M | $76.44M | $75.10M |
| Proceeds from Stock Option Exercised | $753,000.00 | $1.01M | $450,000.00 | $2.49M | $1.16M |
| Net Other Financing Charges | $48.52M | – | – | $73.95M | – |
| Ending Cash Balance | $677.81M | $125.96M | $118.12M | $165.81M | $165.81M |
| Net Change in Cash | $551.88M | $7.85M | -$47.71M | $139.14M | $65.43M |
| Beginning Cash Balance | $125.96M | $118.12M | $165.81M | $26.68M | $100.38M |
| Effect of Exchange Rate Changes | -$26,000.00 | $0.00 | $16,000.00 | -$8,000.00 | $9,000.00 |
| Free Cash Flow | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| Net Common Stock Issuance | – | – | $11.63M | $0.00 | $0.00 |
No comments yet — be the first to weigh in on VKTX.
Sign in to join the discussion.